Biogen (NASDAQ:BIIB) Price Target Lowered to $187.00 at HC Wainwright
Biogen (NASDAQ:BIIB – Free Report) had its target price cut by HC Wainwright from $241.00 to $187.00 in a report issued on Friday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. BIIB has been the subject of a number of other research reports. Argus lowered Biogen from a “buy” rating to […]
Biogen (NASDAQ:BIIB – Free Report) had its target price cut by HC Wainwright from $241.00 to $187.00 in a report issued on Friday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. BIIB has been the subject of a number of other research reports. Argus lowered Biogen from a “buy” rating to […]
